BI 1569912

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BI 1569912, covering 2024-11-13 to 2026-08-14. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication [Phase 1]

See pricing